Oncology & Cancer

MicroRNAs predict recurrence risk of head and neck tumors

A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours. As part of a large-scale study, the authors constructed ...

Oncology & Cancer

Some leukaemia patients may be missing out on new treatments

Patients with an aggressive form of leukaemia, currently ineligible for any type of targeted therapy, may in fact benefit from some of these new drugs, according to new research by Queen Mary University of London.

Oncology & Cancer

Pharmacist finds protein that drives gallbladder tumour growth

Patients with gallbladder cancer often show few or no symptoms for long periods of time. As a result, the tumours are only detected at a late stage of the disease when treatment is often no longer possible. Working in collaboration ...

page 5 from 20